Join BOPA
Back to news articles

CRUK Publication update: National SACT regimen specific consent forms for HPB, Lung and Welsh adult generic forms

By BOPA on 17th October 2024

Dear BOPA memebers,

 

I am pleased to inform you that consent forms for the following groups have been reviewed and updated

 

1. Welsh generic adult SACT and immunotherapy forms

2. Hepato Pancreato Biliary (HPB) cancers – some new forms added

3. Lung cancer – some new forms added



All forms can be found here: www.cruk.org/sact_consent.


 


Best wishes,

Alia

Alia Nizam |Specialist Oncology Pharmacist. CRUK – Information Lead|

					

				

			

		

	






	

		

			
 
				
Latest News

			

		

		

							
 
					

	
 
		By BOPA Executive Committee on 4th November 2025
		
Joint BOPA and PASG Position Statement Safer Handling of Hazardous SACT Drugs: A Pharmacy Workforce Position Statement

		
BOPA and PASG Publish Joint Position Statement on the Safer Handling of Hazardous SACT Drugs The British Oncology Pharmacy Association (BOPA) and the NHS Pharmaceutical Aseptic Services Group (PASG) have…



		Read article
	


				

							
 
					

	
 
		By Jennifer Allen - LCC Lead on 4th November 2025
		
BOPA’s Let’s Communicate Cancer (LCC) series receives re-accreditation from the Royal Society for Public Health (RSPH)

		
The Let’s Communicate Cancer (LCC) series, available for free on the BOPA website CancerHUB: Home Page – BOPA, has recently received re-accreditation from the Royal Society for Public Health which…



		Read article
	


				

							
 
					

	
 
		By BOPA Executive Committee on 3rd November 2025
		
BOPA’s Submission for the National Cancer Plan for England 2025 – Call for Evidence

		
With the National Cancer Plan 2025 for England Publication imminent (Shaping the national cancer plan – GOV.UK) – please find BOPA’s Submission for the call for evidence below: BOPA Submission…



		Read article
	


				

							
 
					

	
 
		By BOPA IOSIG on 1st November 2025
		
IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events

		
  IOCN UK-wide Survey: Access to Immunosuppressants for ICI Adverse Events Have your say on a critical issue affecting immunotherapy patients across the UK. The IOCN and UKSACT Board have…



		Read article